Rasna Therapeutics Inc (RASP)
OTHER OTC:RASP
US Market
Holding RASP?
Track your performance easily

Rasna Therapeutics (RASP) Financial Statements

2 Followers

Rasna Therapeutics Financial Overview

Rasna Therapeutics's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -64.00; Rasna Therapeutics is scheduled to report earnings on May 10, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -86.78K$ -124.32K$ 131.61K$ -100.32K$ 3.81M
EBITDA$ -70.94K$ -124.32K$ 135.49K$ -100.32K$ 3.97M
Net Income Common Stockholders$ -95.52K$ -147.64K$ -58.33K$ -105.16K$ 3.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 19.18K$ 74.99K$ 2.47K$ 2.22K
Total Assets$ 48.61K$ 26.18K$ 95.66K$ 37.06K$ 52.30K
Total Debt$ 96.24K$ 225.70K$ 210.97K$ 215.51K$ 220.40K
Net Debt$ 96.24K$ 206.52K$ 135.99K$ 213.03K$ 218.18K
Total Liabilities$ 1.60M$ 1.74M$ 2.05M$ 2.01M$ 1.92M
Stockholders Equity$ -2.18M$ -2.10M$ -1.96M$ -1.98M$ -1.87M
Cash Flow-
Free Cash Flow$ -35.79K$ -47.29K$ 6.65K$ 9.99K$ -23.77K
Operating Cash Flow$ -35.79K$ -47.29K$ 6.65K$ 9.99K$ -23.77K
Investing Cash Flow-----
Financing Cash Flow$ 18.00K$ -8.51K$ 65.86K$ -9.74K$ -21.57K
Currency in USD

Rasna Therapeutics Earnings and Revenue History

Rasna Therapeutics Debt to Assets

Rasna Therapeutics Cash Flow

Rasna Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis